RaymondLBenzaMDFACC, FAHA, FCCP

Cardiology • New York, NY

Heart Failure & Transplantation

Professor of Medicine Chief Medical Officer PHope

Join to view full profile

Dr. Benza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Benza's full profile

Already have an account?

Office
1 Gustave Levy Place Box 103
Hess building
New York, NY 10029
Phone+1 412-304-8866

Fax+1 212-824-8918

Summary

Professor and System Director for Pulmonary Vascular Diseases at the Icahn School of Medicine at Mount Sinai. He is a Fellow of the AHA and ACC. He holds positions in the PVRI, ISHLT and served on President Barack Obama’s Committee on Organ Transplantation. He was knighted in 2015 for his philanthropic work. Dr. Benza is a Clinical Trialist and funded investigator for the NHLBI and the AHA.

Education & Training

University of Alabama Medical CenterChief Residency, Cardiovascular Disease, 1996 - 1997
University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1993 - 1996
University of MichiganResidency, Internal Medicine, 1990 - 1992
University of MichiganInternship, Internal Medicine, 1989 - 1990
University of Florida College of MedicineClass of 1989

Certifications & Licensure

NY State Medical License 1992 - 2025
OH State Medical License 2020 - 2024
PA State Medical License 2008 - 2021
AL State Medical License 1993 - 2008
MI State Medical License 1991 - 1995
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology

Awards, Honors, & Recognition

College Medallion CHEST, 2024
Association of University Cardiologists 2021
Bob and Corrine Endowed Chair of Heart Failure The Ohio State University, 2020
Best Doctors Pittsburgh 2013-2020
Pittsburgh Health Care Hero Pittsburgh Business Times, 2015, 2019
Fellow american college of chest physicians, 2015
Regional Top Doctor Castle Connolly, 2013-2015
Physician of the Year Pulmonary Hypertension Association, 2012
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012-2013
Knight, Order of Maurice and Lasarus Royal Order of Savoy, Savoy Italy, 2011
James Magovern Chair for Cardiovascular Research Allegheny Singer Research Institute, 2008
Fellow American Heart Association
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management Start of enrollment: 2006 Mar 01
Completed
Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension Start of enrollment: 2006 Aug 01
Completed
Phase 3
Pharmacogenomics in Pulmonary Arterial Hypertension Start of enrollment: 2005 Jul 01
Withdrawn
Effects of Remote Patient Monitoring on Heart Failure Management Start of enrollment: 2009 Mar 01
Completed
Not Applicable
Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
Completed
Phase 2
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies Start of enrollment: 2010 Dec 01
Completed
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2012 Apr 01
Completed
Phase 2
Clinical Study to Evaluate the Safety and Tolerability of Macitentan in Subjects With Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH) Due to Left Ventricular Dysfunction Start of enrollment: 2014 Jul 01
Completed
Phase 2
Effect of iNO on Invasively Derived Pulmonary Pressures in Patients With PAH Start of enrollment: 2016 Apr 01
Completed
Phase 2
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH Start of enrollment: 2017 Oct 20
Completed
Phase 1
Telemonitoring to Treat Group 2 Pulmonary Hypertension Start of enrollment: 2023 Apr 01
Withdrawn
Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

1122 citations
Predicting Survival in Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (R...
Raymond L. Benza, Dave P. Miller, Mardi Gomberg-Maitland, Robert P. Frantz, Aimee J. Foreman
Circulation. 2010-07-13
88 citations
Pulmonary arterial hypertension: epidemiology and registries.
Michael D McGoon, Raymond L Benza, Pilar Escribano-Subias, Xin Jiang, Dave P Miller
Journal of the American College of Cardiology. 2013-12-24
14 citations
Role of Phosphodiesterase-5 Inhibitors in Heart Failure: Emerging Data and Concepts
Manreet Kanwar, Richa Agarwal, Megan Barnes, James C. Coons, Amresh Raina
Current Heart Failure Reports. 2013-03-01

Journal Articles

Clinical Research A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation
Stephen H Bailey, Srinivas Murali, Joseph G Rogers, Raymond Benza, Jeffrey J Teuteberg, Colleen K McIlvennan, Robert L Kormos, JoAnn Lindenfeld, ScienceDirect

Lectures

Highlighted Original Research: Pulmonary Hypertension and Venous Thrombo-Embolic Disease and the Year in Review
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

OSU Wexner Launches 'Hospital-at-Home' Program for Patients with Heart FailureJanuary 28th, 2022
WellSky® to Deliver in-Home Protocols for Patients with Heart FailureJanuary 27th, 2022
United Therapeutics Details New Data Presented at CHEST Annual Meeting 2021October 21st, 2021
Join now to see all

Grant Support

VITA: Vascular Interventions/Innovations and Therapeutic AdvancesNational Heart, Lung and Blood Institute2014–Present
Salivary Gland-Based Gene Therapy for Pulmonary Arterial HypertensionNational Heart, Lung and Blood Institute2013–Present
Pulmonary Hypertension Breakthrough InitiativeAmerican Heart Association2008–Present
Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2008
Pharmacogenomics In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2005–2007
Genetic Determination Of Allograft VasculopathyNational Heart, Lung, And Blood Institute1998–2002